Abstract:Background: Clustered regularly interspaced short palindromic repeats interference (CRISPRi) has provided an efficient approach for targeted gene inhibition. A non-model microorganism Halomonas species TD01 has been developed as a promising industrial producer of polyhydroxyalkanoates (PHA), a family of biodegradable polyesters accumulated by bacteria as a carbon and energy reserve compound. A controllable gene repression system, such as CRISPRi, is needed for Halomonas sp. TD01 to regulate its gene expression levels. Results: For the first time CRISPRi was successfully used in Halomonas sp. TD01 to repress expression of ftsZ gene encoding bacterial fission ring formation protein, leading to an elongated cell morphology with typical filamentous shape similar to phenomenon observed with Escherichia coli. CRISPRi was employed to regulate expressions of prpC gene encoding 2-methylcitrate synthase for regulating 3-hydroxyvalerate monomer ratio in PHBV copolymers of 3-hydroxybutyrate (HB) and 3-hydroxyvalerate (HV). Percentages of HV in PHBV copolymers were controllable ranging from less than 1 to 13%. Furthermore, repressions on gltA gene encoding citrate synthase channeled more acetyl-CoA from the tricarboxylic acid (TCA) cycle to poly(3-hydroxybutyrate) (PHB) synthesis. The PHB accumulation by Halomonas sp. TD01 with its gltA gene repressed in various intensities via CRISPRi was increased by approximately 8% compared with the wild type control containing the CRISPRi vector without target. Conclusions: It has now been confirmed that the CRISPRi system can be applied to Halomonas sp. TD01, a promising industrial strain for production of various PHA and chemicals under open and continuous fermentation process conditions. In details, the CRISPRi system was successfully designed in this study to target genes of ftsZ, prpC and gltA, achieving longer cell sizes, channeling more substrates to PHBV and PHB synthesis, respectively. CRISPRi can be expected to use for more metabolic engineering applications in non-model organisms.

Engineering Halomonas bluephagenesis via small regulatory RNAs

Development of synthetic small regulatory RNA for <i>Rhodococcus erythropolis</i>

Engineering Halomonas species TD01 for enhanced polyhydroxyalkanoates synthesis via CRISPRi

Engineering low-salt growth Halomonas Bluephagenesis for cost-effective bioproduction combined with adaptive evolution

Deficiency of exopolysaccharides and O-antigen makes Halomonas bluephagenesis self-flocculating and amenable to electrotransformation

Development and Application of Transcription Terminators for Polyhydroxylkanoates Production in Halophilic Halomonas Bluephagenesis TD01

Stimulus Response-Based Fine-Tuning of Polyhydroxyalkanoate Pathway in Halomonas.

Gene expression regulation by modulating Hfq expression in coordination with tailor-made sRNA-based knockdown in Escherichia coli

CRISPR/Cas9 editing genome of extremophile Halomonas spp.

Metabolic engineering of Halomonas bluephagenesis to metabolize xylose for poly-3-hydroxybutyrate production

A systems level engineered E. coli capable of efficiently producing L-phenylalanine

Development of an enhanced chromosomal expression system based on porin synthesis operon for halophile Halomonas sp.

A self-stimulating system based on a polyhydroxyalkanoates coupled induction mechanism and its applications for Halomonas

Construction of a Stable Expression System Based on the Endogenous Hbpb/hbpc Toxin-Antitoxin System of Halomonas Bluephagenesis

Novel T7-like expression systems used for Halomonas

Reprogramming Halomonas for industrial production of chemicals

Establishment of genetic tools for genomic DNA engineering of Halomonas sp. KM-1, a bacterium with potential for biochemical production

Engineering Halomonas Bluephagenesis for L-Threonine Production

Construction of new synthetic biology tools for the control of gene expression in the cyanobacterium Synechococcus sp. strain PCC 7002

Flux optimization using multiple promoters in Halomonas bluephagenesis as a model chassis of the next generation industrial biotechnology

Engineering Halomonas TD01 for the low-cost production of polyhydroxyalkanoates.